4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000899243-22-016853
10% owner acquired 5,955,889 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ALS Invest 1 B.V. 10% owner | 2022-01-11 | Conversion | +1,129,386 | 1,129,386 | D | ||
| ALS Invest 1 B.V. 10% owner | 2022-01-11 | Conversion | +4,826,503 | 5,955,889 | D | ||
| Derivatives | |||||||
| ALS Invest 1 B.V. 10% owner | 2022-01-11 | Conversion · Series A Preferred Stock | −1,129,386 | 0 | D | ||
| ALS Invest 1 B.V. 10% owner | 2022-01-11 | Conversion · Series B Preferred Stock | −4,826,503 | 0 | D | ||
Loading xslF345X03/doc4.xml…